Concepedia
Statistics
Publications
5
Citations
546
H-Index
Active since
2011
Affiliations
Pfizer (United States)(Current)
Collaborative Drug Discovery (United States)
Sangeetha Bollini is an author at Pfizer (United States) specializing in medicine, tumor immunity, and cell biology.
Top concepts
MedicineImmunologyBiochemistryCell BiologyImmunotherapyTumor BiologyCancer BiologyTumor ImmunityCancer ResearchInnate Immunity
Publications per year
2011–2020
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration
Jindong Ding, Lincoln V. Johnson, Rolf Herrmann et al. · Proceedings of the National Academy of Sciences · 2011 · 187 citations · Full text
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
Steven E. Kauder, Tracy C. Kuo, Ons Harrabi et al. · PLoS ONE · 2018 · 164 citations · Full text
Adaptive Immune System, Immunology, Immunotherapeutics +18
Structural Basis of C-terminal β-Amyloid Peptide Binding by the Antibody Ponezumab for the Treatment of Alzheimer's Disease
Sherry L. La Porte, Sangeetha Bollini, Thomas A. Lanz et al. · Journal of Molecular Biology · 2011 · 94 citations
Alzheimer's Disease, Biochemistry, Antibody Ponezumab +7
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Tracy C. Kuo, Amy Chen, Ons Harrabi et al. · Journal of Hematology & Oncology · 2020 · 69 citations · Full text
Characterization, Biomarkers, and Reversibility of a Monoclonal Antibody-induced Immune Complex Disease in Cynomolgus Monkeys (<i>Macaca fascicularis</i>)
Jonathan R. Heyen, Jennifer L. Rojko, Mark G. Evans et al. · Toxicologic Pathology · 2014 · 32 citations
1–5 of 5